| scholarly article | Q13442814 |
| P50 | author | Hala F. Zaki | Q53791624 |
| Rehab Hegazy | Q87486307 | ||
| P2093 | author name string | Azza Hassan | |
| Amina Attia | |||
| Nawal Gomaa | |||
| Sara Kenawy | |||
| Siham El-Shenawy | |||
| P2860 | cites work | Comparison of caffeine-induced locomotor activity between adolescent and adult rats. | Q51870382 |
| Aging and Alzheimer's disease: lessons from the Nun Study. | Q53217158 | ||
| Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease | Q57132920 | ||
| Improved method for the determination of blood glutathione | Q79579725 | ||
| Adenosine monophosphate-activated protein kinase in diabetic nephropathy | Q26745623 | ||
| Saponins from Aralia taibaiensis attenuate D-galactose-induced aging in rats by activating FOXO3a and Nrf2 pathways | Q28396841 | ||
| Insulin signalling | Q28611467 | ||
| Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction | Q29616762 | ||
| Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice | Q30419141 | ||
| Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease | Q30760387 | ||
| The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository. | Q31047635 | ||
| Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease | Q33887359 | ||
| Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis | Q34112184 | ||
| Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine | Q34474707 | ||
| Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations | Q35648421 | ||
| Glycogen synthase kinase 3: a drug target for CNS therapies | Q35800094 | ||
| Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway | Q35858703 | ||
| Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis | Q36456393 | ||
| Diabetes medications: Impact on inflammation and wound healing | Q36805643 | ||
| Immunomodulatory effect of tumor necrosis factor | Q37764567 | ||
| Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress | Q37802185 | ||
| Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease. | Q37875108 | ||
| Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes | Q37930196 | ||
| The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. | Q38094984 | ||
| Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism | Q38368300 | ||
| Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation | Q38416332 | ||
| AMPK-mediated regulation of neuronal metabolism and function in brain diseases | Q38539535 | ||
| Targeting Insulin Signaling for the Treatment of Alzheimer's Disease | Q38565622 | ||
| Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System. | Q38718365 | ||
| Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity | Q38737909 | ||
| Metformin: A Hopeful Promise in Aging Research | Q38756907 | ||
| Investing in Health to Create a Third Demographic Dividend | Q38781327 | ||
| Role of oxidative stress in Alzheimer's disease | Q38819665 | ||
| Neuroinflammation in Alzheimer's disease: Current evidence and future directions | Q38834651 | ||
| Oxidative stress, protein modification and Alzheimer disease | Q38868767 | ||
| Defining Rehabilitation Success in Older Adults with Dementia--Results from an Inpatient Geriatric Rehabilitation Unit | Q39901920 | ||
| Anthocyanins Reversed D-Galactose-Induced Oxidative Stress and Neuroinflammation Mediated Cognitive Impairment in Adult Rats | Q40135757 | ||
| Methods for Vascular Access and Collection of Body Fluids from the Laboratory Rat | Q40151522 | ||
| Antidiabetic drugs restore abnormal transport of amyloid-β across the blood-brain barrier and memory impairment in db/db mice | Q40695283 | ||
| Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. | Q41841220 | ||
| A glutamate dehydrogenase-based method for the assay of L-glutamic acid: formation of pyridine nucleotide fluorescent derivatives | Q42020888 | ||
| Morris water maze test for learning and memory deficits in Alzheimer's disease model mice | Q42153622 | ||
| Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms | Q44557854 | ||
| Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease | Q46617604 | ||
| Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides | Q47349499 | ||
| Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease. | Q47895598 | ||
| Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase | Q47903414 | ||
| Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes | Q48157980 | ||
| A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced | Q48179910 | ||
| Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer's disease | Q49066628 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| dementia | Q83030 | ||
| insulin resistance | Q1053470 | ||
| P304 | page(s) | e0183565 | |
| P577 | publication date | 2017-08-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin | |
| P478 | volume | 12 |
| Q60047498 | A Ketogenic Diet Improves Cognition and Has Biochemical Effects in Prefrontal Cortex That Are Dissociable From Hippocampus |
| Q91650986 | Ambrosin, a potent NF-κβ inhibitor, ameliorates lipopolysaccharide induced memory impairment, comparison to curcumin |
| Q64091586 | Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron |
| Q64110048 | Combination of chick embryo and nutrient mixture prevent D-galactose-induced cognitive deficits, immune impairment and oxidative stress in aging rat model |
| Q91810119 | Escitalopram Ameliorates Cognitive Impairment in D-Galactose-Injected Ovariectomized Rats: Modulation of JNK, GSK-3β, and ERK Signalling Pathways |
| Q89446735 | Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats |
| Q92693018 | Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress |
| Q60932964 | Pathogenic Feed-Forward Mechanisms in Alzheimer's and Parkinson's Disease Converge on GSK-3 |
Search more.